MSI in Circulatory DNA of Endometrial Cancer
NCT03744962 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-11-19
Summary
This study aims to analyze the microsatellite instability (MSI) in the circulatory tumor DNA and in the tumor tissue in the patients diagnosed with uterine endometrial cancer. These data will be used for the study of "Cohort Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer" (NCT03291106, clinicaltrials.gov).
Conditions
- Microsatellite Instability
- Lynch Syndrome
- Endometrial Cancer
- Circulating Tumor Cell
Sponsors & Collaborators
-
Lei Li
lead OTHER
Principal Investigators
-
Lei Li, M.D. · Peking Union Medical College Hospital
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-10
- Primary Completion
- 2020-12-23
- Completion
- 2020-12-23
Countries
- China
Study Locations
More Related Trials
-
Registry Study in MSI/dMMR Solid Tumors
NCT06004713 ·Status: RECRUITING
-
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573 ·Status: UNKNOWN
-
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
NCT06895551 ·Status: COMPLETED
-
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
NCT06341855 ·Status: RECRUITING ·Phase: NA
-
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
NCT03015376 ·Status: UNKNOWN
-
Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.
NCT03155451 ·Status: COMPLETED
-
ctDNA Methylation for Epithelial Ovarian Cancer
NCT05801263 ·Status: RECRUITING
-
Chromosomal Instability in Ovarian Cancer
NCT05310357 ·Status: UNKNOWN
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis
NCT03868215 ·Status: UNKNOWN
-
A Multiomics Study Based on the Dynamic Evolution of Endometrial Carcinogenesis
NCT06007300 ·Status: NOT_YET_RECRUITING
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
NCT07270666 ·Status: RECRUITING ·Phase: NA
-
Cell-free DNA Methylation Markers for Cancer Screening
NCT03096938 ·Status: UNKNOWN ·Phase: NA
-
MRI and Metabolomics Biomarkers for Uterine Malignancy
NCT02528864 ·Status: COMPLETED
-
Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome
NCT05257057 ·Status: COMPLETED
-
Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
NCT02638402 ·Status: UNKNOWN
-
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
NCT03614689 ·Status: ACTIVE_NOT_RECRUITING
-
Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53
NCT05755893 ·Status: UNKNOWN
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
NCT05513144 ·Status: UNKNOWN
-
Endometrial Cancer and Array CGH
NCT02833896 ·Status: COMPLETED
-
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria
NCT06469229 ·Status: NOT_YET_RECRUITING
-
Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Biopsy
NCT05334849 ·Status: COMPLETED
-
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
NCT00900289 ·Status: UNKNOWN